Fri, Aug 29, 2014, 5:42 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • michaelroman910 michaelroman910 Dec 21, 2012 8:29 AM Flag

    Barron's " LAZARD CAPITAL Says Commerical Opportunity for SRPT $83 to $139 A Share" LINK

    Barron's Updated 11/21/12 By: Andrew Bary
    Lazard Capital Markets analyst William Tanner said" The US commercial opportunity for Sarepta with eteplirsen implied a stock price of $83 to $139 a share. "

22.93+0.80(+3.62%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.